Summary of SS&C Technologies 2026 Conference Call Company Overview - **Company**: SS&C Technologies (NasdaqGS:SSNC) - **Industry**: Financial Services and Healthcare Technology - **Background**: Established in 1986, SS&C provides mission-critical infrastructure for financial services and healthcare, focusing on technology to differentiate its offerings [3][4] Key Points Business Evolution and Acquisitions - SS&C has transformed from a financial services software company to the world's largest fund administrator and transfer agent through strategic acquisitions, including DST Systems, Intralinks, and Eze in 2018 [5][6] - The company has integrated these acquisitions into its infrastructure, enhancing sales, marketing, and customer retention [6] Financial Performance - SS&C has reduced leverage from 7% to 2.7% since 2018, generating approximately $1.5 billion in free cash flow, resulting in an 8.5% free cash flow yield [7] - The company has prioritized capital allocation towards share buybacks (60%) and debt repayment (30%) [11] Growth and Margin Expansion - SS&C has achieved organic growth of around 5% over the past two years, with expectations to maintain this growth rate in 2026 [35] - The company aims for a 50 basis points margin improvement, targeting a 40% margin by the end of 2026 [43] Technology and AI Integration - SS&C views technology, including AI, as a means to enhance product quality and customer relationships [14] - The acquisition of Blue Prism has enabled SS&C to improve internal efficiencies and productivity, contributing to margin expansion [26] - The company has developed AI Gateway to securely utilize large language models while ensuring data privacy for clients [21] Client Relationships and Retention - SS&C has a strong client retention rate of 96.4%, indicating robust relationships and trust in its services [56] - The company emphasizes the importance of maintaining high customer satisfaction to foster long-term partnerships [53] Market Position and Competitive Dynamics - SS&C believes its established relationships and comprehensive service offerings provide a competitive advantage over startups with limited capabilities [54] - The company is well-positioned to capitalize on market opportunities, particularly in the context of technological advancements and regulatory changes [64] Future Outlook - SS&C is optimistic about its growth trajectory, focusing on customer retention, strategic acquisitions, and leveraging technology to enhance operational efficiency [62] - The company is prepared to navigate market uncertainties while continuing to deliver strong financial results and shareholder returns [66] Additional Insights - The company is exploring opportunities in tokenization through its acquisition of Calastone, which could enhance its service offerings in the asset management space [30][33] - SS&C's healthcare segment, while currently small, is expected to grow significantly as it leverages its new cloud-native system, DomaniRx [40][41]

Core Insights - SS&C Technologies reported record fourth-quarter results with adjusted revenue of $1.655 billion, an 8% increase year-over-year, and adjusted diluted earnings per share of $1.69, up 18% [4][7] - The company anticipates continued organic growth and margin expansion in 2026, with guidance for revenue between $6.65 billion and $6.74 billion and adjusted EPS between $6.70 and $7.02 [5][18] Financial Performance - GAAP fourth-quarter revenue was $1.654 billion, with net income of $193 million or $0.77 per diluted share [1] - Adjusted net income was $425 million, reflecting a 16.8% increase, and adjusted consolidated EBITDA reached $651 million, up 9% with a margin of 39.3% [4][8] - Operating cash flow for the year was $1.745 billion, with cash-flow conversion exceeding 100% for three consecutive years [6][9] Growth Drivers - Adjusted organic revenue growth for the quarter was 5.3% on a constant-currency basis, driven by strong performance in Global Investor & Distribution Solutions (GIDS) and GlobeOp, with revenue increases of 13.2% and 9.6% respectively [3] - The company is focusing on international growth, particularly in Australia, leveraging opportunities tied to recent superannuation mandates [3] Shareholder Returns - SS&C returned $384 million to shareholders in Q4, including $319 million in share repurchases and $66 million in dividends [10] - The company repurchased over $1 billion of stock in 2025, indicating a strong commitment to share buybacks in the absence of high-quality acquisition opportunities [6][10] Strategic Initiatives - Management views outsourcing and "lift-outs" as sustainable growth engines, with ongoing integration of the Calastone acquisition [5][12] - AI is considered a competitive advantage, with SS&C deploying AI solutions rapidly, leveraging its proprietary software and data [14][15] 2026 Outlook - The company expects to maintain strong performance throughout 2026, with guidance reflecting a focus on expense management, productivity, and technology leverage [16][17] - Q1 2026 guidance includes revenue of $1.608 billion to $1.648 billion and adjusted net income of $404 million to $420 million [18]

Financial Data and Key Metrics Changes - SS&C reported record adjusted revenue of $1.655 billion for Q4 2025, an increase of 8% year-over-year [5] - Adjusted diluted earnings per share (EPS) reached $1.69, reflecting an 18% increase [5] - Adjusted consolidated EBITDA was a record $651 million, up 9%, with an EBITDA margin of 39.3% [5][12] - Cash from operating activities for the full year was $1.745 billion, up 26% year-over-year [7] Business Line Data and Key Metrics Changes - GIDS experienced a revenue growth of 13.2%, while GlobeOp saw a 9.6% increase [6] - Intralinks showed modest growth in Q4, with expectations for momentum in 2026 [6] - The healthcare business faced challenges, but management remains optimistic about long-term growth opportunities [21][23] Market Data and Key Metrics Changes - The company is focusing on international growth opportunities, particularly in Australia with GlobeOp [6] - The alternative fund administration business showed exceptional growth in assets under administration, with expectations for continued growth in 2026 [27] Company Strategy and Development Direction - SS&C is leveraging AI and automation as a competitive advantage, believing it will drive long-term growth and profitability [4][19] - The company is prioritizing share repurchases and is optimistic about the early progress of the Calastone acquisition [8][19] - Management emphasized the importance of maintaining strong client relationships and expanding service offerings [10] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges in the healthcare sector but remains confident in the market's potential [21][23] - The company expects to maintain strong organic growth throughout 2026, with a focus on recurring revenue and long-term client partnerships [33] - Management is optimistic about the impact of AI on operational efficiency and competitive positioning [10][35] Other Important Information - SS&C ended Q4 with $462 million in cash and cash equivalents and $7.5 billion in gross debt, resulting in a net leverage ratio of 2.8 times [15] - The company plans to maintain capital expenditures at 4.4%-4.8% of revenues and continue share buybacks similar to 2025 levels [16] Q&A Session Summary Question: What drove the weakness in the healthcare business? - Management indicated that healthcare is a long-term play and noted the challenges of quarter-to-quarter comparisons, citing large license sales in the previous year [21][22] Question: Update on the Elevance relationship? - Management stated that DomaniRx is ready for onboarding, but highlighted the challenges of navigating relationships within large healthcare organizations [24] Question: Insights on alternative fund administration growth? - Management confirmed strong organic growth in the alternative fund administration sector, attributing part of the growth to the acquisition of Curo Fund Services [27] Question: Outlook for the intelligent automation business? - Management expressed optimism for the intelligent automation business, noting that it is a key area for innovation and growth [28][30] Question: Expectations for organic growth in wealth management? - Management is optimistic about the wealth management business, particularly the Black Diamond platform, which is expected to continue driving growth [38] Question: M&A environment insights? - Management is actively looking for acquisition opportunities and believes they are well-positioned to pursue larger acquisitions if the right opportunity arises [39]

Financial Data and Key Metrics Changes - SS&C Technologies reported record adjusted revenue of $1.655 billion for Q4 2025, an increase of 8% year-over-year, and adjusted diluted earnings per share of $1.69, reflecting an 18% increase [5][11] - Adjusted consolidated EBITDA reached a record $651 million, up 9%, with an adjusted EBITDA margin of 39.3% [5][12] - Cash from operating activities for the full year was $1.745 billion, up 26% year-over-year, with operating cash flow per share at $6.89, an increase of $1.42 from 2024 [7][14] Business Line Data and Key Metrics Changes - GIDS experienced a revenue growth of 13.2%, while GlobeOp saw a 9.6% increase in revenue [6] - Intralinks showed signs of improvement with modest growth in Q4, indicating potential momentum for 2026 [6] - The healthcare business faced challenges, with management noting that it is a long-term play and subject to regulatory complexities [21][23] Market Data and Key Metrics Changes - The company is focusing on international growth opportunities, particularly in Australia, leveraging recent superannuation mandates [6] - The alternative fund administration business showed exceptional growth in assets under administration, with expectations for continued strong performance in 2026 [27] Company Strategy and Development Direction - SS&C is prioritizing investments in artificial intelligence and automation, believing these will enhance efficiency and scalability, thereby strengthening competitive positioning [4][10] - The company is committed to returning capital to shareholders through share repurchases, having allocated over $1 billion in 2025 for this purpose [8][19] - Management expressed optimism about the Calastone acquisition and its potential for geographic expansion and growth opportunities [8][19] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the sell-off in software company shares but emphasized SS&C's strong market position and deep expertise [4] - The company expects to maintain strong organic growth and margin expansion, with guidance for Q1 2026 revenue between $1.608 billion and $1.648 billion [16][17] - Management remains confident in the sustainability of growth driven by long-term client partnerships and the advancement of AI technologies [9][10] Other Important Information - The effective non-GAAP tax rate for Q4 2025 was 19.2%, with a full-year effective tax rate of 22% [13] - SS&C ended Q4 with $462 million in cash and cash equivalents and a net debt of $7 billion, resulting in a net leverage ratio of 2.8 times [15] Q&A Session Summary Question: Concerns about the healthcare business's organic growth - Management noted that healthcare is a long-term play and highlighted the challenges of quarter-to-quarter comparisons, mentioning a notable multimillion-dollar license closed in early January 2026 [21][22] Question: Update on the Elevance relationship - Management indicated that DomaniRx is ready for onboarding but acknowledged the complexities of relationships within large healthcare organizations [24] Question: Growth expectations for alternative fund administration - Management confirmed strong organic growth in the alternative fund administration business and high expectations for 2026, attributing part of the growth to the acquisition of Curo Fund Services [27] Question: Outlook for the intelligent automation business - Management expressed optimism about the intelligent automation business, noting that it is a key area for innovation and expected to align with overall corporate organic growth rates [28][30] Question: Organic growth guidance for 2026 - Management stated that the strength of the business allows for more predictability in organic growth, with expectations for strong performance throughout the year [33] Question: Competitive advantage against emerging AI fintechs - Management emphasized the challenges of building a large organization and the importance of regulatory compliance, asserting that SS&C is well-positioned to maintain its competitive edge [34][35] Question: Medium-term outlook for wealth and investment management - Management expressed optimism about the wealth management business, highlighting the success of the Black Diamond platform and its integration with other services [38] Question: M&A environment and acquisition strategy - Management indicated ongoing interest in acquisitions, noting that they are well-positioned to pursue larger opportunities if the right targets are identified [40][41]

Financial Data and Key Metrics Changes - SS&C Technologies reported record adjusted revenue of $1.655 billion for Q4 2025, an increase of 8% year-over-year, and adjusted diluted earnings per share of $1.69, reflecting an 18% increase [5][10] - Adjusted consolidated EBITDA reached a record $651 million, up 9%, with an adjusted EBITDA margin of 39.3% [5][11] - Cash from operating activities for the full year was $1.745 billion, up 26% year-over-year, with operating cash flow per share at $6.89, an increase of $1.42 from 2024 [6][12] Business Line Data and Key Metrics Changes - GIDS experienced a revenue growth of 13.2%, while GlobeOp saw a 9.6% revenue increase, contributing significantly to the overall performance [5][10] - Intralinks showed signs of improvement with modest growth in Q4, indicating potential momentum for 2026 [6] Market Data and Key Metrics Changes - The company is focusing on international growth opportunities, particularly in Australia, leveraging recent superannuation mandates [5] - The healthcare business is viewed as a long-term play, with expectations for future growth despite current headwinds [20] Company Strategy and Development Direction - The company is optimistic about the AI boom, viewing it as a tailwind for growth, and is rapidly deploying AI solutions to enhance efficiency and scalability [4][9] - SS&C is prioritizing share repurchases and is open to high-quality, accretive acquisitions, with over $1 billion allocated for share repurchases in 2025 [6][7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the durability of growth drivers, emphasizing long-term partnerships that create recurring revenue [8][9] - The company anticipates continued strong performance in 2026, with guidance for revenue in the range of $6.65 billion to $6.74 billion and organic growth of 5.1% at the midpoint [15][16] Other Important Information - The effective non-GAAP tax rate for Q4 2025 was 19.2%, with a full-year effective tax rate of 22% [12] - The company ended Q4 with $462 million in cash and cash equivalents and a net debt of $7 billion, resulting in a net leverage ratio of 2.8 times [13] Q&A Session Summary Question: What drove the weakness in the healthcare business? - Management noted that healthcare is a long-term play and highlighted the lumpy nature of large license sales, with optimism for future growth due to new technology [20][21] Question: Update on the Elevance relationship? - Management indicated that DomaniRx is ready for onboarding, but challenges exist due to the size and complexity of Elevance's existing relationships [22] Question: Insights on alternative fund administration growth? - Management confirmed strong organic growth in the alternative fund administration sector, with expectations for continued growth in 2026, partly driven by the acquisition of Curo Fund Services [25] Question: Outlook for the intelligent automation business? - Management expressed optimism for the intelligent automation business, noting that it is a key area for innovation and growth, particularly with AI advancements [26][27] Question: Organic growth guidance for 2026? - Management stated that the consistent organic growth guidance reflects a stronger business with more predictability and recurring revenue [31] Question: Competitive advantage against emerging AI fintechs? - Management emphasized the challenges of building a large organization compared to starting a fintech, highlighting the importance of regulatory compliance and established client relationships [32][33] Question: Medium-term outlook for wealth and investment management? - Management expressed optimism for the wealth management business, citing the strength of the Black Diamond platform and ongoing integration efforts [36][38] Question: M&A environment insights? - Management indicated ongoing interest in acquisitions, noting that they are well-positioned to pursue larger opportunities if the right targets are identified [39][40]